Candesartan cilexetil clinical trials
Also written Atacand and Atacand 16mg.
A product of Candesartan; its studies count on that page too.
How each study uses candesartan cilexetil is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the candesartan cilexetil studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 4 Jun 1998 · ATACAND · NDA 020838 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
38 studies that test it; most in 2013 (5)
| Year | Studies |
|---|---|
| 1998 | 2 |
| 2001 | 2 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 4 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 5 |
| 2014 | 4 |
| 2015 | 2 |
| 2017 | 1 |
| 2019 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 25 · Other 14
AstraZeneca (10) · HK inno.N Corporation (3) · GlaxoSmithKline (3) · Shin Poong Pharmaceutical Co. Ltd. (2) · Takeda (2) · Hospital Israelita Albert Einstein (1) · Uppsala University (1) · Pharmtechnology LLC (1)
Often tested with
Tested in the same studies.
Amlodipine (5) · Hydrochlorothiazide (3) · Lisinopril (2) · Ramipril (2) · Chlorthalidone (1) · Rosuvastatin (1) · Allopurinol (1) · Fimasartan (1)
Related medicines
As reviewed, each with the page that says it.
- A salt or form of Candesartan
- One of Angiotensin II Type 1 Receptor Blockers source
- One of Angiotensin receptor blockers (ARBs) source
Studies
Open first, then newest update. How each study uses candesartan cilexetil is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 39
- Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)Enrolling by invitationPhase 4Baylor Research InstituteNCT07547878Written as AtacandHow we know
- Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain InjuryEnrolling by invitationPhase 2University of California, San FranciscoNCT05826912Written as Candesartan CilexetilHow we know
- Candesartan Cilexetil + Chlorthalidone + Amlodipine Versus Exforge HCT®️ for Systemic Arterial HypertensionCompletedPhase 3Hospital Israelita Albert EinsteinNCT05920005Written as candesartan cilexetil + chlorthalidone + amlodipineHow we know
- Controlled Trial of Angiotensin Receptor Blocker (ARB) & Chemokine Receptor Type 2 (CCR2) Antagonist for the Treatment of COVID-19TerminatedPhase 2University of SydneyNCT05122182Written as Candesartan CilexetilHow we know
- A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Candesartan Cilexetil MonotherapyCompletedPhase 3HK inno.N CorporationNCT02368652Written as Candesartan cilexetil 16mgHow we know
- The Precision Hypertension Care StudyCompletedPhase 4Uppsala UniversityNCT02774460Written as Atacand®How we know
- The Bioequivalence Study of Two Different Formulations of Candesartan Cilexetil After a Single Oral Dose Administration Under Fasting ConditionsCompletedPhase 1Pharmtechnology LLCNCT04012307Written as Candesartan Cilexetil 32mgHow we know
- A Pilot Study of Candesartan as a Treatment for Cocaine DependenceTerminatedPhase 2Baylor College of MedicineNCT01938664Written as Candesartan with CBTHow we know
- Relative Bioavailability Study of Candesartan Cilexetil Under Fasting ConditionsCompletedPhase 1GlaxoSmithKlineNCT02254447Written as ATACANDHow we know
- Bioavailability Study of Candesartan Cilexetil 16mg Tablet Under Fasting ConditionsCompletedPhase 1GlaxoSmithKlineNCT02006602Written as Candesartan cilexetil (GW615775, Test formulation)How we know
- Renal Response to Lower Body Negative Pressure in Pre-hypertensive StatesCompletedPhase 4PD Dr. Grégoire WuerznerNCT01734096Written as Candesartan cilexetilHow we know
- Bioavailability Study of Candesartan Cilexetil 8mg Tablet Under Fasting ConditionsCompletedPhase 1GlaxoSmithKlineNCT02006589Written as Candesartan cilexetil (GW615775, Test formulation)How we know
- Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential HypertensionCompletedPhase 2BayerNCT01303783Written as Candesartan cilexetil (Atacand), 4 mgHow we know
- Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential HypertensionCompletedPhase 2Shin Poong Pharmaceutical Co. Ltd.NCT02944734Written as Candesartan Cilexetil 8mgHow we know
- Clinical Trial to Compare the Pharmacokinetics of DP-R208CompletedPhase 1Alvogen KoreaNCT02707224Written as Candesartan cilexetilHow we know
- Investigate a Interaction of Candesartan and Atorvastatin in Healthy Male SugjectsStatus unknownPhase 1Ahn-Gook Pharmaceuticals Co.,LtdNCT02609711Written as Candesartan cilexetilHow we know
- Diabetic Retinopathy Candesartan TrialsCompletedPhase 3AstraZenecaNCT00252733Written as candesartan cilexetilHow we know
- A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential HypertensionStatus unknownPhase 2HK inno.N CorporationNCT02059616Written as Candesartan Cilexetil 8mgHow we know
- Safety and Pharmacokinetics Study of Amlodipine 10mg and Candesartan 32mgCompletedPhase 1Shin Poong Pharmaceutical Co. Ltd.NCT01926652Written as candesartan cilexetil 32mg, amlodipine 10mgHow we know
- Pharmacokinetic Interactions of Candesartan Cilexetil and Amlodipine BesylateStatus unknownPhase 1HK inno.N CorporationNCT01845272Written as candesartan cilexetil 32mg, amlodipine 10mgHow we know
See all 39 studies that test candesartan cilexetil →
Given beside what is tested · 6 — candesartan cilexetil is usual care or a partner of the new treatment
- Safety and Tolerability of MK-5478 in Participants With Hypertension (5478-001)CompletedPhase 1Merck Sharp & Dohme LLCNCT01025843Written as Comparator: Candesartan cilexetilHow we know
- Efficacy and Safety of a Therapy Change From Candesartan 32 mg to Fixed Combination of Olmesartan 40 mg/Amlodipine 10 mgCompletedPhase 4Institut für Pharmakologie und Präventive MedizinNCT01611077Written as Candesartan cilexetilHow we know
- DP-R208 Pharmacokinetic StudyCompletedPhase 1Alvogen KoreaNCT02709187Written as Candesartan cilexetilHow we know
- Sevicontrol-1: Efficacy and Safety of a Fixed Combination of Olmesartan/ AmlodipineCompletedPhase 3Institut für Pharmakologie und Präventive MedizinNCT01613209Written as Candesartan cilexetilHow we know
- Bioequivalence Study of CJ-30059Status unknownPhase 1HK inno.N CorporationNCT02173912Written as Candesartan cilexetil 16 mg and Amlodipine besylate 10mg (Reference)How we know
- Candesartan Effect in Second Stage Arterial HypertensionCompletedPhase 4AstraZenecaNCT00621153Written as Candesartan CilexetilHow we know
As the comparator · 8 — what is tested is compared with candesartan cilexetil
- Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination TabletsCompletedPhase 4HK inno.N CorporationNCT03847506Written as Candesartan cilexetil/Amlodipine besylateHow we know
- A Phase 2 Dose-finding Study of TAK-272 in Participants With Type 2 Diabetes Mellitus and MicroalbuminuriaCompletedPhase 2TakedaNCT02332824Written as Candesartan cilexetilHow we know
- Monotherapy-Controlled Study of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Combination in Subjects With Essential Hypertension Inadequately Controlled on Candesartan CilexetilWithdrawnPhase 3BayerNCT02047019Written as Candesartan CilexetilHow we know
- Single Dose Bioequivalence Study Comparing Nifedipine/Candesartan FDC (Fixed Dose Combination) With Loose Combination of Nifedipine GITS (Gastro-intestinal Therapeutic System) Plus Candesartan and Single Components Under Fasting ConditionsCompletedPhase 1BayerNCT01227603Written as Candesartan (Atacand)How we know
- Benefits of Medical Therapy Plus Stenting for Renal Atherosclerotic LesionsCompletedPhase 3Baim Institute for Clinical ResearchNCT00081731Written as Atacand/HCT, CaduetHow we know
- To Evaluate the Efficacy and Safety on Blood Pressure In Patients With Hypertension Diagnosed Congestive Heart FailureCompletedPhase 4Chong Kun Dang PharmaceuticalNCT01682564Written as Atacand tabletHow we know
- Effects of Telmisartan on Ischemic Cardiovascular Events in High-risk Hypertensive PatientsTerminatedNot applicableKyoto Prefectural University of MedicineNCT00863980Written as Blopress (Candesartan)How we know
- Efficacy and Safety of Azilsartan in Participants With Mild to Moderate Uncomplicated Essential HypertensionCompletedPhase 2TakedaNCT01289132Written as Candesartan cilexetilHow we know
Codes
What other systems call candesartan cilexetil · ClinicalTrials.gg INT003675
- MeSH (NLM) C077793candesartan cilexetilConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) R85M2X0D68CANDESARTAN CILEXETILConfirmed FDA, NLM, Wikidata
- RxNorm 135481Confirmed FDA, Wikidata
- Wikidata Q27075664candesartan cilexetilConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C28903Candesartan CilexetilOne source FDA
- DrugBank DB00796One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C077793 | candesartan cilexetil | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | R85M2X0D68 | CANDESARTAN CILEXETIL | Confirmed FDA, NLM, Wikidata |
| RxNorm | 135481 | — | Confirmed FDA, Wikidata |
| Wikidata | Q27075664 | candesartan cilexetil | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C28903 | Candesartan Cilexetil | One source FDA |
| DrugBank | DB00796 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.